This gentle yet effective detoxification process not only clears heavy metals but also promotes improved circulation and reduced inflammation
Managing Expectations and Celebrating Plateau Stability Reaching a plateau is actually a success marker: it means your body has achieved a new, lower, stable weight that the medication is actively maintaining
As oestrogen declines, you naturally lose muscle mass and retain less body water
Beyond these primary endpoints, TRIUMPH-1 includes a range of secondary and exploratory endpoints that paint a fuller picture of retatrutide's clinical impact: Proportion of participants achieving 10%, 15%, and 20% or greater weight loss Changes in waist circumference Changes in cardiometabolic risk factors, including blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, and fasting glucose Changes in HbA1c (a measure of average blood sugar over the preceding two to three months) Changes in liver enzymes and markers of hepatic health Patient-reported outcomes related to quality of life and physical function Safety and tolerability, including the incidence and severity of adverse events The secondary endpoints are particularly important for retatrutide because the Phase 2 data showed striking improvements across metabolic markers
